Literature DB >> 16935860

Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation.

Ilaria Bertani1, Laura Rusconi, Fabrizio Bolognese, Greta Forlani, Barbara Conca, Lucia De Monte, Gianfranco Badaracco, Nicoletta Landsberger, Charlotte Kilstrup-Nielsen.   

Abstract

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X-linked infantile spasms sharing the common features of generally intractable early seizures and mental retardation. Disease-causing mutations are distributed in both the catalytic domain and in the large COOH terminus. In this report, we examine the functional consequences of some Rett mutations of CDKL5 together with some synthetically designed derivatives useful to underline the functional domains of the protein. The mutated CDKL5 derivatives have been subjected to in vitro kinase assays and analyzed for phosphorylation of the TEY (Thr-Glu-Tyr) motif within the activation loop, their subcellular localization, and the capacity of CDKL5 to interact with itself. Whereas wild-type CDKL5 autophosphorylates and mediates the phosphorylation of the methyl-CpG-binding protein 2 (MeCP2) in vitro, Rett-mutated proteins show both impaired and increased catalytic activity suggesting that a tight regulation of CDKL5 is required for correct brain functions. Furthermore, we show that CDKL5 can self-associate and mediate the phosphorylation of its own TEY (Thr-Glu-Tyr) motif. Eventually, we show that the COOH terminus regulates CDKL5 properties; in particular, it negatively influences the catalytic activity and is required for its proper sub-nuclear localization. We propose a model in which CDKL5 phosphorylation is required for its entrance into the nucleus whereas a portion of the COOH-terminal domain is responsible for a stable residency in this cellular compartment probably through protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935860     DOI: 10.1074/jbc.M606325200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.

Authors:  Greta Forlani; Elisa Giarda; Ugo Ala; Ferdinando Di Cunto; Monica Salani; Rossella Tupler; Charlotte Kilstrup-Nielsen; Nicoletta Landsberger
Journal:  Hum Mol Genet       Date:  2010-05-26       Impact factor: 6.150

2.  Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity.

Authors:  Maria Fazzari; Angelisa Frasca; Francesco Bifari; Nicoletta Landsberger
Journal:  RNA Biol       Date:  2019-06-23       Impact factor: 4.652

3.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

4.  Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.

Authors:  Przemyslaw Szafranski; Sailaja Golla; Weihong Jin; Ping Fang; Patricia Hixson; Reuben Matalon; Daniel Kinney; Hans-Georg Bock; William Craigen; Janice L Smith; Weimin Bi; Ankita Patel; Sau Wai Cheung; Carlos A Bacino; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2014-10-15       Impact factor: 4.246

5.  Diolistic Labeling and Analysis of Dendritic Spines.

Authors:  M Foster Olive; Armani P Del Franco; Cassandra D Gipson
Journal:  Methods Mol Biol       Date:  2018

6.  A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain.

Authors:  Sarah L Williamson; Laura Giudici; Charlotte Kilstrup-Nielsen; Wendy Gold; Gregory J Pelka; Patrick P L Tam; Andrew Grimm; Dionigio Prodi; Nicoletta Landsberger; John Christodoulou
Journal:  Hum Genet       Date:  2011-07-12       Impact factor: 4.132

Review 7.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

8.  Novel mutations in cyclin-dependent kinase-like 5 (CDKL5) gene in Indian cases of Rett syndrome.

Authors:  Dhanjit Kumar Das; Bhakti Mehta; Shyla R Menon; Sarbani Raha; Vrajesh Udani
Journal:  Neuromolecular Med       Date:  2012-12-15       Impact factor: 3.843

9.  Palmitoylation-dependent CDKL5-PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development.

Authors:  Yong-Chuan Zhu; Dan Li; Lu Wang; Bin Lu; Jing Zheng; Shi-Lin Zhao; Rong Zeng; Zhi-Qi Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

10.  CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.

Authors:  Laura Rusconi; Lisa Salvatoni; Laura Giudici; Ilaria Bertani; Charlotte Kilstrup-Nielsen; Vania Broccoli; Nicoletta Landsberger
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.